GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 32.470
AS - Asia 12.323
EU - Europa 10.384
SA - Sud America 1.666
Continente sconosciuto - Info sul continente non disponibili 346
AF - Africa 316
OC - Oceania 45
Totale 57.550
Nazione #
US - Stati Uniti d'America 31.752
SG - Singapore 3.861
GB - Regno Unito 3.563
CN - Cina 3.329
IT - Italia 2.311
HK - Hong Kong 1.452
BR - Brasile 1.290
VN - Vietnam 1.169
SE - Svezia 824
DE - Germania 792
UA - Ucraina 595
FI - Finlandia 571
BD - Bangladesh 552
TR - Turchia 462
RU - Federazione Russa 420
FR - Francia 363
CA - Canada 345
KR - Corea 330
IN - India 252
BG - Bulgaria 224
MX - Messico 142
ID - Indonesia 131
AR - Argentina 119
ES - Italia 117
NL - Olanda 110
IQ - Iraq 105
PK - Pakistan 100
PL - Polonia 97
JP - Giappone 89
ZA - Sudafrica 80
IE - Irlanda 79
AE - Emirati Arabi Uniti 57
EG - Egitto 56
EC - Ecuador 54
CO - Colombia 47
IR - Iran 47
PH - Filippine 46
MA - Marocco 45
AU - Australia 41
TH - Thailandia 40
VE - Venezuela 40
LT - Lituania 39
MY - Malesia 38
SA - Arabia Saudita 38
CL - Cile 37
BE - Belgio 33
CR - Costa Rica 31
JM - Giamaica 31
PE - Perù 31
CH - Svizzera 28
KE - Kenya 27
UZ - Uzbekistan 27
HN - Honduras 26
DZ - Algeria 24
TT - Trinidad e Tobago 24
RO - Romania 23
TN - Tunisia 23
IL - Israele 22
SV - El Salvador 22
AT - Austria 21
AZ - Azerbaigian 20
CZ - Repubblica Ceca 20
EE - Estonia 20
UY - Uruguay 20
JO - Giordania 18
PT - Portogallo 18
PY - Paraguay 18
GT - Guatemala 17
NP - Nepal 17
GR - Grecia 16
HU - Ungheria 16
PR - Porto Rico 16
KG - Kirghizistan 15
DK - Danimarca 14
ET - Etiopia 13
KZ - Kazakistan 13
PA - Panama 13
NI - Nicaragua 12
AL - Albania 11
TW - Taiwan 11
BH - Bahrain 10
OM - Oman 10
BO - Bolivia 9
SN - Senegal 9
GH - Ghana 8
LB - Libano 8
NG - Nigeria 8
RS - Serbia 8
NO - Norvegia 7
PS - Palestinian Territory 7
SY - Repubblica araba siriana 7
BS - Bahamas 6
DO - Repubblica Dominicana 6
MK - Macedonia 6
SM - San Marino 6
BY - Bielorussia 5
KH - Cambogia 5
MD - Moldavia 5
SC - Seychelles 5
SI - Slovenia 5
Totale 57.102
Città #
Ashburn 4.123
Fairfield 2.484
Southend 2.476
Singapore 2.264
Santa Clara 2.243
Woodbridge 1.621
Hong Kong 1.426
Houston 1.286
Jacksonville 1.162
Hefei 1.107
Chandler 1.040
San Jose 1.026
Seattle 941
Council Bluffs 870
Wilmington 850
Ann Arbor 771
Cambridge 751
Dearborn 656
Beijing 612
London 596
Los Angeles 594
Nyköping 500
Chicago 452
Ho Chi Minh City 375
The Dalles 364
Helsinki 344
Modena 340
Seoul 314
Hanoi 281
Milan 267
Buffalo 254
New York 250
San Diego 242
Princeton 238
Dallas 220
Sofia 217
Eugene 187
Lauterbourg 183
Columbus 172
São Paulo 166
Izmir 163
Salt Lake City 162
Shanghai 114
Munich 112
Moscow 110
Atlanta 107
Rome 102
Orem 98
Des Moines 95
Phoenix 93
Austin 91
San Francisco 86
Toronto 85
Bologna 80
Boardman 79
Frankfurt am Main 76
Guangzhou 75
Elk Grove Village 73
Dublin 71
Tampa 70
Bremen 67
Tokyo 66
Redwood City 65
Denver 63
Montreal 62
North Bergen 61
Jakarta 59
Washington 58
Philadelphia 57
Brooklyn 56
Naples 54
Haiphong 52
Miami 52
Warsaw 52
Kent 50
Da Nang 46
Mexico City 44
Norwalk 43
Detroit 41
Miano 41
Rio de Janeiro 41
Istanbul 40
Turku 39
Boston 38
Honolulu 38
Lancaster 38
Baghdad 37
Falls Church 37
Charlotte 33
Sterling 33
Chennai 32
Florence 32
Turin 32
Cagliari 31
Johannesburg 30
Saint Augustine 30
Amsterdam 29
Dhaka 29
Mumbai 28
Parma 28
Totale 37.971
Nome #
Combined myo-inositol and Banaba (1% Corosolic Acid) improve HOMA-IR and hepatic insulin extraction index in overweight and obese postmenopausal women 731
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 684
Inositol as putative integrative treatment for PCOS 635
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 565
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 482
Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol 469
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 435
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 435
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 432
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 420
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 406
Alla scoperta dei minerali dell'Isola d'Elba: itinerari e note per la ricerca sulle pegmatiti del Monte Capanne 392
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 389
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 372
Neuroendocrinological Aspects of a Tailored Hormonal Contraception 366
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 362
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 361
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 353
Diagnostic and therapeutic approach to hypothalamic amenorrhea 353
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 351
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 348
Inositol and human reproduction. From cellular metabolism to clinical use 347
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 347
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 343
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 341
Use of metformin in the treatment of polycystic ovary syndrome 339
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 335
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 335
Allopregnanolone concentrations and premenstrual syndrome 334
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 333
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 329
Life events impact in patients with secondary amenorrhoea. 326
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 322
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 320
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 319
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 318
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 316
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 316
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 316
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 313
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 312
The relevance of inositols treatment for PCOS before and during ART 311
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 308
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 304
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 299
Advances in neurosteroids: Role in clinical practice 298
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 295
Subclinical Atherosclerosis at Peripheral Arteries in Obese Individuals. 295
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 294
Obesità e benessere: i rischi per la salute della donna obesa 293
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 293
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 290
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 289
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 288
Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients 283
Functional Hypothalamic Amenorrhea as Stress Induced Defensive System 283
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 277
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 275
The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications 274
Adrenal function under long-term raloxifene administration 273
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 272
Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome. A randomized study. 272
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both 272
Neuroendocrine mechanisms of mood disorders during menopause transition: A narrative review and future perspectives 271
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies 270
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 270
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 270
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 269
Episodic secretion of activin A in pregnant women 268
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 267
Metabolismo osseo nelle amenorreaa ipotalamiche da basso peso: il ruolo del trattamento con estroprogestinici 261
Corticotropin-releasing factor-binding protein: Origins and possible functions 261
Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans 260
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 259
Prolactin as a neuroendocrine clue in sexual function of women across the reproductive life cycle: an expert point of view 258
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 257
Female precocious puberty, obesity and polycystic-like ovaries 257
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 257
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 256
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 254
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 254
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 254
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 253
DHEA as a putative replacement therapy in the elderly 253
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 251
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 249
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 248
Effects of red clover extracts on breast cancer cell migration and invasion 248
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 248
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 248
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 248
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 247
Aging modifies the hormonal responses in women. 247
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 247
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 247
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 243
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome 242
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 239
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 239
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 238
Totale 31.648
Categoria #
all - tutte 223.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 223.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.143 0 0 0 0 63 116 277 198 345 211 533 400
2022/20233.137 348 269 172 271 391 517 52 285 422 45 150 215
2023/20242.303 92 145 141 152 551 197 242 315 36 72 145 215
2024/20257.938 334 105 80 608 1.507 1.010 355 487 1.067 720 763 902
2025/202616.663 1.044 714 1.610 1.644 2.192 1.300 1.906 897 1.678 1.562 1.127 989
2026/20278.638 1.456 2.033 1.996 3.082 71 0 0 0 0 0 0 0
Totale 57.550